Switching antihypertensives improves BP control better than upping dose alone: study
A personalised treatment approach resulted in an extra 4.4mmHg reduction in systolic blood pressure, found the researchers.
Patients on tailored antihypertensive monotherapy could see a twofold reduction in blood pressure than what could be achieved by simply increasing the dose alone, Swedish and Australian doctors report.
Their repeated crossover trial comparing four different blood pressure–lowering drug classes showed that a personalised approach could provide an additional 4.4mmHg drop in systolic blood pressure, on average, than a fixed dose.
